Recombinant protein expression is a cornerstone of modern biotechnology, fueling advances in drug development, molecular ...

Viral vectors are engineered viruses that are used to deliver genetic material into cells for various applications, such as gene therapy, vaccine development, and biotechnology research. These viruses ...

Single cell gene expression studies often rely on single-cell RNA sequencing (scRNA-seq) alone. While scRNA-seq reveals which genes are turned on, it does not capture protein expression or changes to ...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma ...

US biotech Cirrus Therapeutics has emerged from stealth with $11 million in seed financing to advance a gene therapy for dry ...

In a development that could help protect one of the world's most beloved agricultural commodities, a research team at Penn ...

Krystal Biotech, Inc.’s KRYS lead drug Vyjuvek is a non-invasive, topical, redosable gene therapy approved in the United States, Europe, and Japan for the treatment of dystrophic epidermolysis bullosa ...

Oral presentation highlights safe, robust reduction in apoC-III and triglycerides by MB-111, paving the way to the clinic in 2026.

Krystal Biotech reports positive clinical data for KB408 and KB407, demonstrating safety and efficacy in AATD and cystic fibrosis patients. Krystal Biotech, Inc. has announced promising clinical ...